U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
NTSB Opens Investigation Into Waymo Robotaxis After School Bus Safety Violations in Texas 
Winter Storm Triggers Widespread Flight Cancellations Across U.S. as Airlines Urge Travelers to Rebook 
FSU Criticizes ANZ Over Suncorp Bank Job Cuts Amid Post-Acquisition Commitments 
BitGo IPO Prices Above Range, Raises $212.8M in Landmark Crypto Market Debut 
Ericsson Plans SEK 25 Billion Shareholder Returns as Margins Improve Despite Flat Network Market 
ByteDance Finalizes Majority U.S.-Owned TikTok Joint Venture to Avert American Ban 
Walmart to Cut PhonePe Stake in IPO as Tiger Global and Microsoft Exit 
Valero Makes First Venezuelan Crude Purchase Under New U.S.-Caracas Deal 
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
Apple China Holiday Sale Offers Discounts Up to 1,000 Yuan on Popular Devices 
SEC Drops Gemini Enforcement Case After Full Repayment to Earn Investors 
Exxon Mobil’s XTO Energy Explores Sale of Eagle Ford Shale Assets in South Texas 
Memory Chip Shortage Drives Higher Gadget Prices and Weakens Global Tech Demand 
Intel Stock Slides Despite Earnings Beat as Weak Q1 Outlook Raises Concerns 
Morgan Stanley Flags High Volatility Ahead for Tesla Stock on Robotaxi and AI Updates 
Goldman Sachs CEO David Solomon’s 2025 Pay Soars to $47 Million After Strong Deal-Making Year 
Among the highlights of the March 2017 quarterly performance report for the ERI Scientific Beta indices:
- Scientific Beta Multi-Beta Multi-Strategy indices provide an allocation to well-rewarded smart factor indices. Over the past ten years, the SciBeta Developed Multi-Beta Multi-Strategy 4-Factor EW (Equal Weight) index, the SciBeta Developed High Factor Exposure Multi-Beta Multi-Strategy 6-Factor EW index and the SciBeta Developed Multi-Beta Multi-Strategy Max Factor Exposure index post strong annual relative returns of 1.21%, 2.80% and 2.94% respectively compared to cap-weighted indices.
- This quarter, the SciBeta Developed Multi-Beta Multi-Strategy 4-Factor EW index, the SciBeta Developed High Factor Exposure Multi-Beta Multi-Strategy 6-Factor EW index and the SciBeta Developed Multi-Beta Multi-Strategy Max Factor Exposure index post relative returns of -0.34%, -0.34% and -0.08% respectively compared to cap-weighted indices.
- Looking at the live performance of Scientific Beta Multi-Beta Multi-Strategy indices, the best performance was obtained by the SciBeta Japan Multi-Beta Multi-Strategy 4-Factor EW index with a relative return of 4.83%, while the lowest performance was obtained by the Developed Asia Pacific ex Japan High Factor Exposure Multi-Beta Multi-Strategy 6-Factor EW index with a relative return of -1.77%.
As part of its policy of transferring know-how to the industry, EDHEC-Risk Institute has set up ERI Scientific Beta. ERI Scientific Beta is an original initiative which aims to favour the adoption of the latest advances in smart beta design and implementation by the whole investment industry. Its academic origin provides the foundation for its strategy: offer, in the best economic conditions possible, the smart beta solutions that are most proven scientifically with full transparency of both the methods and the associated risks.
ERI Scientific Beta, 1 George Street, #07-02, Singapore 049145. For further information, please contact: Carolyn Essid, Tel.: +33 493 187 824, E-mail: [email protected], Web: www.scientificbeta.com.
Find out more about the research conducted by EDHEC-Risk Institute on smart beta and the Scientific Beta indices by following us on Twitter (https://twitter.com/ScientificBeta), LinkedIn (https://www.linkedin.com/company/scientific-beta) and YouTube (https://www.youtube.com/channel/UCRL91F-LvhLPc9M9OD7LQgA).
Attachments:
http://www.globenewswire.com/NewsRoom/AttachmentNg/8f9e2cdf-5ffe-4f0e-b4f3-49ee46064539
